The calprotectin testing market is anticipated to secure a valuation of US$ 201.1 billion in 2023 and is projected to reach US$ 360.2 billion by 2033. The market is capturing a CAGR of 6% during the forecast period.
Why do Healthcare Professionals Increase the Adoption of Calprotectin Testing?
The healthcare sector is rapidly growing due to its innovations and adoption of advanced technologies to develop sufficient and reliable devices. Healthcare professionals are using calprotectin testing to monitor inflammatory bowel disease efficiently. The increasing adoption of calprotectin testing help to monitor and detect patients’ diagnosis and perform their treatment process quickly.
Equip yourself with the tools for progress and prosperity – get our Sample Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-14504
These testing tools are easy to use, accurate, and improve patients’ conditions, surging the market revenue. Healthcare professionals can manage and detect inflammatory bowel disease on time and monitor calprotectin levels. Healthcare professionals increase the demand for calprotectin testing to treat patients’ gastrointestinal disorders and monitor inflammatory diseases.
Recent Trends in the Global Calprotectin Testing Market:
The several notable trends in the global market are as follows:
- There is rising demand for non-invasive diagnostic devices by healthcare providers and patients to produce quick and accurate results.
- The prevalence of inflammatory bowel disease is growing rapidly. Therefore, the demand for calprotectin testing is increasing to monitor patients’ chronic health.
- The innovation of advanced technology devices is more reliable and tract patients’ health accurately.
- Adopting automation in calprotectin testing reduces error risk, detects efficiently, and increases productivity.
Key Takeaways:
- The calprotectin testing market is securing a valuation of US$ 360.2 billion with a CAGR of 6% by 2033.
- The United States is anticipated to lead the global market by registering a share of 25.7% by 2033.
- Japan is anticipated to register a share of 3.1% in the global market during the forecast period.
- In the historic period, the market captured a CAGR of 5.3% between 2018 and 2022.
Key Players are Executing Plans to Rise the Market Size:
The key players are executing various plans to upsurge the global market are:
- New Product Launches: key players are developing user-friendly, sustainable, and accurate testing devices in the market. They are launching these testing tools to satisfy patients’ requirements.
- Collaboration:Key companies collaborate with stakeholders, research organizations, and hospitals to enhance product quality. These collaborations help them to reach relevant customers and increase sales.
- Promotions and Marketing:Key players invest in promotional and marketing to expand their business and brand value. They promote their products on social media and educate patients about the benefits of their products.
These are a few strategies key players adopt to increase the market size.
- Actim Oy
- Calpro AS
- BÜHLMANN Laboratories AG
- EagleBio
- CerTest Biotec S.L.
- EUROIMMUN Medizinische Labordiagnostika AG
- Boditech Med Inc.
- Biohit Oyj
- American Laboratory Products Company, Ltd.
- DIAsource ImmunoAssays S.A
- R-Biopharm AG.
Enrich Your Thinking With Our Comprehensive Methodology Now! https://www.futuremarketinsights.com/request-report-methodology/rep-gb-14504
Recent Developments in the Global Market are:
- In 2020, Biohit Oyj launched its new product Calprotectin ELISA kit. It is designed to collect human samples to monitor inflammatory bowel disease.
- In 2021, Techlab Inc launched Enteric BioFire FilmArray Panel to detect gastrointestinal infections.
- In 2021, EKF Diagnostics launched its point-of-care device to measure calprotectin. This device provides accurate and fast results to monitor patients’ diseases.
Calprotectin Testing Market by Category:
By Test Kits:
- Calprotectin ELISA Test Kits
- Calprotectin Rapid Testing Kits
By Sample:
- Stool, Blood Serum/Plasma
- Other Biological Samples
By Indication:
- Irritable Bowel Syndrome
- Ulcerative Colitis
- Crohn’s Disease
- Colorectal Cancer
By End User:
- Hospitals
- Diagnostic Laboratories
- Specialty Clinics
Region:
- North America
- Europe
- Latin America
- Asia Pacific
- The Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube